JW Pharmaceutical announced on the 12th that it has launched a new hangover relief product called the 'Ganettoktok Hangover Relief Stick'.


This product is a grape-flavored jelly stick, with each stick containing 2,000 mg of a complex blend as its main ingredient, including young barley sprout extract concentrate. It also contains 10 mg of L-arginine, 10 mg of milk thistle extract powder, 10 mg of taurine, and a range of B vitamins as supplementary ingredients.

JW Pharmaceutical 'Ganetoktok Hangover Relief Stick' product. JW Pharmaceutical

JW Pharmaceutical 'Ganetoktok Hangover Relief Stick' product. JW Pharmaceutical

View original image

As a jelly stick formulation, it can be taken without water and is easy to carry, making it convenient to use in various everyday situations, such as before or after company dinners or gatherings.


The Ganettoktok Hangover Relief Stick is a functional labeled food product whose hangover relief efficacy has been certified by the Ministry of Food and Drug Safety. The product packaging is marked with the phrase "Human Clinical Trial for Hangover Relief Effect Completed" to help consumers easily identify its features.


JW Pharmaceutical plans to first introduce the product mainly through pharmacies, and later expand the sales channels beyond pharmacies according to consumer response and its brand expansion strategy.


Additionally, the company intends to extend the product lineup of its existing liver disease adjuvant therapy brand, Ganettok, into areas such as hangover relief, and increase brand awareness particularly among office workers in their 20s to 40s.



A JW Pharmaceutical representative stated, "The Ganettoktok Hangover Relief Stick is a product designed with both functionality and convenience in mind," adding, "We will continue to expand the Ganettok brand lineup to offer consumers products they can easily choose for daily liver health."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing